C Difficile

8500 bookmarks
Custom sorting
Unveiling the hidden world of gut health: Exploring cutting-edge research through visualizing randomized controlled trials on the gut microbiota - PubMed
Unveiling the hidden world of gut health: Exploring cutting-edge research through visualizing randomized controlled trials on the gut microbiota - PubMed
The study highlights the rapid growth and importance of research on RCTs that involve the gut microbiota. This study provides valuable insight into research trends, identifies key players, and outlines potential future directions in this field. Additionally, the co-occurrence analysis identified imp …
·pubmed.ncbi.nlm.nih.gov·
Unveiling the hidden world of gut health: Exploring cutting-edge research through visualizing randomized controlled trials on the gut microbiota - PubMed
Small Intestinal Permeability and Metabolomic Profiles in Feces and Plasma Associate With Clinical Response in Patients With Active Psoriatic Arthritis Participating in a Fecal Microbiota Transplantation Trial: Exploratory Findings From the FLORA Trial - PubMed
Small Intestinal Permeability and Metabolomic Profiles in Feces and Plasma Associate With Clinical Response in Patients With Active Psoriatic Arthritis Participating in a Fecal Microbiota Transplantation Trial: Exploratory Findings From the FLORA Trial - PubMed
Intestinal permeability and fecal and plasma metabolomic profiles of patients with PsA were associated with the primary clinical trial end point, failure versus responder.
·pubmed.ncbi.nlm.nih.gov·
Small Intestinal Permeability and Metabolomic Profiles in Feces and Plasma Associate With Clinical Response in Patients With Active Psoriatic Arthritis Participating in a Fecal Microbiota Transplantation Trial: Exploratory Findings From the FLORA Trial - PubMed
Infection nosocomiale à C. difficile : la transmission à l'hôpital en question
Infection nosocomiale à C. difficile : la transmission à l'hôpital en question
Les patients porteurs asymptomatiques de Clostridioides difficile (anciennement Clostridium difficile) sont-ils des réservoirs cachés d'infections nosocomiales ? S'ils le sont très rarement pour les autres, les porteurs asymptomatiques à l'admission sont 24 fois plus à risque de développer une infection clinique.
·news.google.com·
Infection nosocomiale à C. difficile : la transmission à l'hôpital en question
A Potent and Narrow-Spectrum Antibacterial against Clostridioides difficile Infection - PubMed
A Potent and Narrow-Spectrum Antibacterial against Clostridioides difficile Infection - PubMed
Clostridioides difficile is an anaerobic Gram-positive bacterium that colonizes the gut of patients treated with broad-spectrum antibiotics. The normal gut microflora prevents C. difficile colonization; however, dysbiosis by treatment with broad-spectrum antibiotics causes recur …
·pubmed.ncbi.nlm.nih.gov·
A Potent and Narrow-Spectrum Antibacterial against Clostridioides difficile Infection - PubMed
Strategies for applying probiotics in the antibiotic management of Clostridioides difficile infection - PubMed
Strategies for applying probiotics in the antibiotic management of Clostridioides difficile infection - PubMed
The vital role of probiotics in the food field has been widely recognized, and at the same time, probiotics are gradually exhibiting surprising effects in the field of nutraceuticals, especially in regulating gut inflammation and the nutritional environment. As a dietary supplement in clinical nutri …
·pubmed.ncbi.nlm.nih.gov·
Strategies for applying probiotics in the antibiotic management of Clostridioides difficile infection - PubMed
Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Clostridioides difficile infection challenge in vivo - PubMed
Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Clostridioides difficile infection challenge in vivo - PubMed
Our findings, demonstrating in vivo efficacy of ADS024 in protecting against CDI challenge in mouse models, support the use of ADS024 in preventing recurrent CDI following standard antibiotic treatment.
·pubmed.ncbi.nlm.nih.gov·
Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Clostridioides difficile infection challenge in vivo - PubMed
Phenolic Substitution in Fidaxomicin: A Semisynthetic Approach to Antibiotic Activity Across Species - PubMed
Phenolic Substitution in Fidaxomicin: A Semisynthetic Approach to Antibiotic Activity Across Species - PubMed
Fidaxomicin (Fdx) is a natural product antibiotic with potent activity against Clostridioides difficile and other Gram-positive bacteria such as Mycobacterium tuberculosis. Only few Fdx derivatives have been synthesized and examined for their biological activity in the 50 years since its discovery. …
·pubmed.ncbi.nlm.nih.gov·
Phenolic Substitution in Fidaxomicin: A Semisynthetic Approach to Antibiotic Activity Across Species - PubMed
A US-based national surveillance study for the susceptibility and epidemiology of Clostridioides difficile isolates with special reference to ridinilazole: 2020-2021 - PubMed
A US-based national surveillance study for the susceptibility and epidemiology of Clostridioides difficile isolates with special reference to ridinilazole: 2020-2021 - PubMed
We have previously reported on the susceptibility and epidemiology of Clostridioides difficile isolates from six geographically dispersed medical centers in the United States. This current survey was conducted with isolates collected in 2020-2021 from six geographically dispersed medical cent …
·pubmed.ncbi.nlm.nih.gov·
A US-based national surveillance study for the susceptibility and epidemiology of Clostridioides difficile isolates with special reference to ridinilazole: 2020-2021 - PubMed
https://news.google.com/rss/articles/CBMilQFodHRwczovL3d3dy51c25ld3MuY29tL25ld3MvaGVhbHRoLW5ld3MvYXJ0aWNsZXMvMjAyMy0wOS0yMC9wYXRpZW50LXRvLXBhdGllbnQtdHJhbnNtaXNzaW9uLW5vdC10by1ibGFtZS1mb3ItbW9zdC1jLWRpZmZpY2lsZS1pbmZlY3Rpb25zLWluLWhvc3BpdGFsc9IBAA?oc=5
https://news.google.com/rss/articles/CBMilQFodHRwczovL3d3dy51c25ld3MuY29tL25ld3MvaGVhbHRoLW5ld3MvYXJ0aWNsZXMvMjAyMy0wOS0yMC9wYXRpZW50LXRvLXBhdGllbnQtdHJhbnNtaXNzaW9uLW5vdC10by1ibGFtZS1mb3ItbW9zdC1jLWRpZmZpY2lsZS1pbmZlY3Rpb25zLWluLWhvc3BpdGFsc9IBAA?oc=5
·news.google.com·
https://news.google.com/rss/articles/CBMilQFodHRwczovL3d3dy51c25ld3MuY29tL25ld3MvaGVhbHRoLW5ld3MvYXJ0aWNsZXMvMjAyMy0wOS0yMC9wYXRpZW50LXRvLXBhdGllbnQtdHJhbnNtaXNzaW9uLW5vdC10by1ibGFtZS1mb3ItbW9zdC1jLWRpZmZpY2lsZS1pbmZlY3Rpb25zLWluLWhvc3BpdGFsc9IBAA?oc=5
Expanding our grasp of two-component signaling in Clostridioides difficile - PubMed
Expanding our grasp of two-component signaling in Clostridioides difficile - PubMed
The intestinal pathogen Clostridioides difficile encodes roughly 50 TCS, but very few have been characterized in terms of their activating signals or their regulatory roles. A. G. Pannullo, B. R. Zbylicki, and C. D. Ellermeier (J Bacteriol 205:e00164-23, 2023, https://doi.org/10.1128/jb.00164 …
·pubmed.ncbi.nlm.nih.gov·
Expanding our grasp of two-component signaling in Clostridioides difficile - PubMed
Long-term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data over Eight Years from the Hong Kong FMT Registry - PubMed
Long-term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data over Eight Years from the Hong Kong FMT Registry - PubMed
This prospective real-world data from Asia's first FMT registry demonstrated that FMT has an excellent long-term safety profile. The risk of developing new medical conditions beyond 12 months after FMT is low.
·pubmed.ncbi.nlm.nih.gov·
Long-term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data over Eight Years from the Hong Kong FMT Registry - PubMed
Gut microbiota signature in children with autism spectrum disorder who suffered from chronic gastrointestinal symptoms - PubMed
Gut microbiota signature in children with autism spectrum disorder who suffered from chronic gastrointestinal symptoms - PubMed
Overall, these results confirm that there are significant differences in the gut microbiota structure between children with ASD and healthy controls in the southeast coastal region of China. This underscores the critical significance of delving into clinical interventions capable of mitigating the g …
·pubmed.ncbi.nlm.nih.gov·
Gut microbiota signature in children with autism spectrum disorder who suffered from chronic gastrointestinal symptoms - PubMed
Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Clostridioides difficile infection challenge in vivo - PubMed
Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Clostridioides difficile infection challenge in vivo - PubMed
Our findings, demonstrating in vivo efficacy of ADS024 in protecting against CDI challenge in mouse models, support the use of ADS024 in preventing recurrent CDI following standard antibiotic treatment.
·pubmed.ncbi.nlm.nih.gov·
Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Clostridioides difficile infection challenge in vivo - PubMed
Effects of two strains of Lactobacillus isolated from the feces of calves after fecal microbiota transplantation on growth performance, immune capacity, and intestinal barrier function of weaned calves - PubMed
Effects of two strains of Lactobacillus isolated from the feces of calves after fecal microbiota transplantation on growth performance, immune capacity, and intestinal barrier function of weaned calves - PubMed
verall, these results showed that the two strains isolated from cattle feces after low concentration fecal microbiota transplantation improved the growth performance, immune performance, antioxidant capacity, and intestinal barrier function of weaned calves, indicating their potential as supplements …
·pubmed.ncbi.nlm.nih.gov·
Effects of two strains of Lactobacillus isolated from the feces of calves after fecal microbiota transplantation on growth performance, immune capacity, and intestinal barrier function of weaned calves - PubMed
Clostridioides (Clostridium) difficile: A silent nosocomial pathogen - PubMed
Clostridioides (Clostridium) difficile: A silent nosocomial pathogen - PubMed
Clostridioides difficile (C. difficile) infection is still a threat to many healthcare settings worldwide. Clostridioides difficile epidemiology has changed over the last 20 years, largely due to the emergence of hypervirulent and antimicrobial-resistant C. difficile strains. Th …
·pubmed.ncbi.nlm.nih.gov·
Clostridioides (Clostridium) difficile: A silent nosocomial pathogen - PubMed
Novel ribotype/sequence type associations and diverse CRISPR-Cas systems in environmental Clostridioides difficile strains from Northern Iraq - PubMed
Novel ribotype/sequence type associations and diverse CRISPR-Cas systems in environmental Clostridioides difficile strains from Northern Iraq - PubMed
The environment is a natural reservoir of Clostridioides difficile and here, we aimed to isolate the pathogen from seven locations in Northern Iraq. Four of the sites yielded thirty-one isolates (ten from soils, twenty-one from sediments) which together represent ribotypes 001 (five), 010 (five), 01 …
·pubmed.ncbi.nlm.nih.gov·
Novel ribotype/sequence type associations and diverse CRISPR-Cas systems in environmental Clostridioides difficile strains from Northern Iraq - PubMed
Living With C diff: A Unique Perspective as Patient and Provider
Living With C diff: A Unique Perspective as Patient and Provider
Mollie Lauck, NP, has both battled C diff herself and treated patients with the bacterial infection. In the second installment of our interview, she talks about her clinical approach to patients who might be considered candidates for C diff and specific strategies for infection prevention.
·news.google.com·
Living With C diff: A Unique Perspective as Patient and Provider
Strategies for applying probiotics in the antibiotic management of Clostridioides difficile infection - PubMed
Strategies for applying probiotics in the antibiotic management of Clostridioides difficile infection - PubMed
The vital role of probiotics in the food field has been widely recognized, and at the same time, probiotics are gradually exhibiting surprising effects in the field of nutraceuticals, especially in regulating gut inflammation and the nutritional environment. As a dietary supplement in clinical nutri …
·pubmed.ncbi.nlm.nih.gov·
Strategies for applying probiotics in the antibiotic management of Clostridioides difficile infection - PubMed
Discrimination between hypervirulent and non-hypervirulent ribotypes of Clostridioides difficile by MALDI-TOF mass spectrometry and machine learning - PubMed
Discrimination between hypervirulent and non-hypervirulent ribotypes of Clostridioides difficile by MALDI-TOF mass spectrometry and machine learning - PubMed
Hypervirulent ribotypes (HVRTs) of Clostridioides difficile such as ribotype (RT) 027 are epidemiologically important. This study evaluated whether MALDI-TOF can distinguish between strains of HVRTs and non-HVRTs commonly found in Europe. Obtained spectra of clinical C. difficile isolates (training …
·pubmed.ncbi.nlm.nih.gov·
Discrimination between hypervirulent and non-hypervirulent ribotypes of Clostridioides difficile by MALDI-TOF mass spectrometry and machine learning - PubMed
The Impacts of Fecal Microbiota Transplantation from Same Sex on the Symptoms of Ulcerative Colitis Patients - PubMed
The Impacts of Fecal Microbiota Transplantation from Same Sex on the Symptoms of Ulcerative Colitis Patients - PubMed
We aimed to compare the clinical efficacy of fecal microbiota transplantation (FMT) from the same sex on ulcerative colitis (UC) patients. A total of 272 UC patients were selected in the prospective clinical study, which incorporated four distinct groups, each comprising male and female patients, wh …
·pubmed.ncbi.nlm.nih.gov·
The Impacts of Fecal Microbiota Transplantation from Same Sex on the Symptoms of Ulcerative Colitis Patients - PubMed
Discrimination between hypervirulent and non-hypervirulent ribotypes of Clostridioides difficile by MALDI-TOF mass spectrometry and machine learning - PubMed
Discrimination between hypervirulent and non-hypervirulent ribotypes of Clostridioides difficile by MALDI-TOF mass spectrometry and machine learning - PubMed
Hypervirulent ribotypes (HVRTs) of Clostridioides difficile such as ribotype (RT) 027 are epidemiologically important. This study evaluated whether MALDI-TOF can distinguish between strains of HVRTs and non-HVRTs commonly found in Europe. Obtained spectra of clinical C. difficile isolates (training …
·pubmed.ncbi.nlm.nih.gov·
Discrimination between hypervirulent and non-hypervirulent ribotypes of Clostridioides difficile by MALDI-TOF mass spectrometry and machine learning - PubMed